Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript : vimarsana.com

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2023 Earnings Call Transcript February 28, 2024 Amicus Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning ladies and gentlemen and welcome to the Amicus Therapeutics’ Full Year 2023 Financial Results Conference […]

Related Keywords

United Kingdom , Germany , San Diego , California , United States , Austria , Bradley Campbell , Jeff Castelli , Simon Harford , Jeff Gatseli , Asia Pacific , Middle East , Pompe Disease , Chief Development Officer , Amicus Pompe , Annual World Symposium , Treatment Award , Chief Financial Officer , Pompeii Phase , Thanks Simon , Buy According , Future Stocks For The Long , Amicus Therapeutics , Are Disease , Chief Executive Officer , Hief Medical Officer , Andrew Faughnan , Xchange Rates ,